Funders · Entity Annotation Prototype (beta)

2articles mentioning funders

2funder mentions

1distinct funders extracted

0%of mentions human-reviewed

NCT04221477

This funder is selected. Its supporting articles are shown below.

2 articles · page 1 of 1

lupusscimed · abstract · 2026-03-01 · 1 matching annotations

91.5%

…Objectives The REGENCY trial ( NCT04221477) evaluated obinutuzumab plus standard therapy (OBI+ST) compared…

lupusscimed · abstract · 2026-03-01 · 1 matching annotations

88.0%

…Objectives The REGENCY trial ( NCT04221477) demonstrated superiority of obinutuzumab (OBI) plus standard t…